Association between the cardiac abnormalities in COVID-19 patients, and disease severity and mortality

Condensed and commented by Claudio López Bruzual MD Although many cases of COVID-19 are mild or asymptomatic, and most patients recover from the disease, cardiovascular, pulmonary, and neurological complications from COVID-19 infections have been reported that are not yet fully understood. Cardiac abnormalities, specifically, have been detected through the use of biomarkers and imaging in […]

LDL as a marker for controlling atherosclerosis

By Claudio López Bruzual, MD. Considering LDL (bad cholesterol) as a target marker for our efforts to control the atherosclerotic disease is already an old debate. In a new work of the Copenhagen General Population Study,13015 patients treated withstatins were followed. The purpose was to determine the residual risk of death from any cause, and […]

Congenital Heart Defect (CHD): Definition, Statistics, and EKG Support from SCHILLER

Table of Contents   Introduction Congenital Heart Defect (CHD), also referred to as Congenital Heart Disease, describes abnormalities in the structure or function of the heart present at birth. The American Heart Association prefers the term defect as it more accurately reflects a developmental anomaly rather than an acquired condition (American Heart Association, 2023). Etiology […]